Management of recalcitrant hidradenitis suppurativa with ustekinumab

Acta Derm Venereol. 2012 May;92(3):320-1. doi: 10.2340/00015555-1229.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Drug Resistance
  • Hidradenitis Suppurativa / complications
  • Hidradenitis Suppurativa / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Psoriasis / complications
  • Psoriasis / drug therapy
  • Ustekinumab

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Ustekinumab